Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices 3549 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–01262 Filed 1–21–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Health Statistics 

(NCHS), ICD–10 Coordination and 

Maintenance (C&M) Committee 

Meeting 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of virtual meeting. 

SUMMARY: The CDC, National Center for 

Health Statistics (NCHS), Classifications 

and Public Health Data Standards Staff, 

announces the following meeting of the 

ICD–10 Coordination and Maintenance 

(C&M) Committee meeting. This 

meeting is open to the public, limited 

only by audio lines available. Online 

Registration is not required. 

DATES: The meeting will be held on 

March 8, 2022, from 9:00 a.m. to 5:00 

p.m., EST, and March 9, 2022, from 9:00 

a.m. to 5:00 p.m., EST. 

ADDRESSES: This is a virtual meeting. 

Information will be provided on each of 

our respective web pages when it 

becomes available. For CDC/NCHS 

https://www.cdc.gov/nchs/icd/icd10cm_

maintenance.htm. For CMS https://

www.cms.gov/Medicare/Coding/ 

ICD9ProviderDiagnosticCodes/meetings. 

FOR FURTHER INFORMATION CONTACT: 

Traci Ramirez, Medical Systems 

Specialist, CDC, 3311 Toledo Road, 

Hyattsville, Maryland 20782, 

Telephone: (301) 458–4454; Email: 

TRamirez@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The ICD–10 Coordination 

and Maintenance (C&M) Committee is a 

public forum for the presentation of 

proposed modifications to the 

International Classification of Diseases, 

Tenth Revision, Clinical Modification 

and ICD–10 Procedure Coding System. 

Matters To Be Considered: The 

tentative agenda will include 

discussions on ICD–10–CM and ICD– 

10–PCS topics listed below. Agenda 

items are subject to change as priorities 

dictate. Please refer to the posted agenda 

for updates one month prior to the 

meeting. 

ICD–10–PCS Topics 

1. Administration of Spesolimab * 

2. Administration of daratumumab and 

hyaluronidase-fihj * 

3. Administration of Defencath * 

4. Administration of Maribavir * 

5. Administration of Teclistamab * 

6. Administration of Mosunetuzumab * 

7. Administration of afamitresgene 

autoleucel ** 

8. Administration of tabelecleucel ** 

9. Administration of Treosulfan * 

10. Administration of inebilizumab-cdon * 

11. Administration of Xenon-129 * 

12. Administration of betibeglogene 

autotemcel ** 

13. Administration of Omidubicel ** 

14. Implantation of Sphenopalatine Ganglion 

Stimulator for Ischemic Stroke * 

15. Gene Expression Assay ** 

16. Vertebral Body Tethering * 

17. Percutaneous Femoral-Popliteal Artery 

Bypass * 

18. Computer-Assisted Transcranial Magnetic 

Stimulation * 

19. Computer-Aided Analysis for the 

Detection and Classification of Epileptic 

Events * 

20. Facet Replacement Spinal Stabilization 

Device * 

21. Insertion of Sacropelvic Fixation 

System * 

22. Insertion of an Implantable Vagus Nerve 

Stimulation System * 

23. Insertion of a Paired Vagus Nerve 

Stimulation System * 

24. Percutaneous Venous Thrombectomy for 

Postthrombotic Syndrome * 

25. Quantitative Flow Ratio for Non-invasive 

Intraprocedural Analysis of Cardiac 

Angiography 

26. Application of Allogeneic Thymus 

Derived Tissue 

27. Supersaturated Oxygen Therapy 

28. Assistance with Precision Stimulation 

Software * 

29. Section X Updates 

30. Addenda and Key Updates 

* Requestor has submitted a New 

Technology Add-on Payment (NTAP) 

application for FY 2023. 

** Requestor intends to submit an 

NTAP application for FY 2024 

consideration. 

Presentations for procedure code 

requests are conducted by both the 

requestor and CMS during the 

Coordination & Maintenance Committee 

meeting. Discussion from the requestor 

generally focuses on the clinical issues 

for the procedure or technology, 

followed by the proposed coding 

options from a CMS analyst. Topics 

presented may also include requests for 

new procedure codes that relate to a 

new technology add-on payment 

(NTAP) policy request. 

CMS is continuing to modify the 

approach for presenting the new 

technology add-on payment (NTAP) 

related ICD–10–PCS procedure code 

requests that involve the administration 

of a therapeutic agent for the March 8– 

9, 2022 ICD–10 Coordination and 

Maintenance Committee meeting. 

Consistent with the requirements of 

section 1886(d)(5)(K)(iii) of the Social 

Security Act, applicants submitted 

requests to create a unique procedure 

code to describe the administration of a 

therapeutic agent, such as the option to 

create a new code in Section X within 

the ICD–10–PCS procedure code 

classification. CMS will initially only 

display those meeting materials 

associated with the NTAP related ICD– 

10–PCS procedure code requests that 

involve the administration of a 

therapeutic agent on the CMS website in 

early February 2022 at: https://

www.cms.gov/Medicare/Coding/ICD10/ 

C-and-M-Meeting-Materials. 

The 13 NTAP related ICD–10–PCS 

procedure code requests that involve the 

administration of a therapeutic agent 

are: 

1. Administration of Spesolimab * 

2. Administration of daratumumab and 

hyaluronidase-fihj * 

3. Administration of Defencath * 

4. Administration of Maribavir * 

5. Administration of Teclistamab * 

6. Administration of Mosunetuzumab * 

7. Administration of afamitresgene 

autoleucel ** 

8. Administration of tabelecleucel ** 

9. Administration of Treosulfan * 

10. Administration of inebilizumab-cdon * 

11. Administration of Xenon-129 * 

12. Administration of betibeglogene 

autotemcel ** 

13. Administration of Omidubicel ** 

These topics will not be presented 

during the March 8–9, 2022 meeting. 

CMS will solicit public comments 

regarding any clinical questions or 

coding options included for these 13 

procedure code topics in advance of the 

meeting continuing through the end of 

the public comment period, April 8, 

2022. Members of the public should 

send any questions or comments to the 

CMS mailbox at: ICDProcedure 

CodeRequest@cms.hhs.gov by the April 

8, 2022 deadline. 

CMS intends to post a question and 

answer document in advance of the 

meeting to address any clinical or 

coding questions that members of the 

public may have submitted. Following 

the conclusion of the meeting, CMS will 

post an updated question and answer 

document to address any additional 

clinical or coding questions that 

members of the public may have 

submitted during the meeting that CMS 

was not able to address or that were 

submitted after the meeting. 

The NTAP related ICD–10–PCS 

procedure code requests that do not 

involve the administration of a 


jspears on DSK121TN23PROD with NOTICES1
3550 Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices 

therapeutic agent and all non-NTAP 

related procedure code requests will 

continue to be presented during the 

virtual meeting on March 8, 2022, 

consistent with the standard meeting 

process. 

CMS will make all meeting materials 

and related documents available at: 

https://www.cms.gov/Medicare/Coding/ 

ICD10/C-and-M-Meeting-Materials. Any 

inquiries related to the procedure code 

topics scheduled for the March 8–9, 

2022 ICD–10 Coordination and 

Maintenance Committee meeting that 

are under consideration for October 1, 

2022 implementation should be sent to 

the CMS mailbox at: ICDProcedure 

CodeRequest@cms.hhs.gov. 

ICD–10–CM Topics 

1. Coma 

2. Craniosynostosis 

3. Extraocular muscle entrapment 

4. Foreign body sensation 

5. Impairing Emotional Outbursts 

6. Insulin resistant syndrome 

7. Leukodystrophies 

8. Observation and evaluation of newborn for 

other specified suspected condition ruled 

out 

9. Problems related to upbringing 

10. Addenda 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–01283 Filed 1–21–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; ORR–1, Cash and Medical 

Assistance Program Estimates 

AGENCY: Office of Refugee Resettlement, 

Administration for Children and 

Families, HHS. 

ACTION: Request for public comment. 

SUMMARY: The Office of Refugee 

Resettlement (ORR), Administration for 

Children and Families (ACF), U.S. 

Department of Health and Human 

Services (HHS) is requesting a 3-year 

extension of the form ORR–1, Cash and 

Medical Assistance Program Estimates 

(OMB #0970–0030, expiration 5/31/ 

2022). There are no changes requested 

to the form or instructions. 

DATES: Comments due within 60 days of 

publication. In compliance with the 

requirements of section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

ACF is soliciting public comment on the 

specific aspects of the information 

collection described above. 

ADDRESSES: Copies of the proposed 

collection of information can be 

obtained and comments may be 

forwarded by emailing infocollection@

acf.hhs.gov. Identify all requests by the 

title of the information collection. 

SUPPLEMENTARY INFORMATION: 

Description: The ORR–1, Cash and 

Medical Assistance Program Estimates, 

is the application for grants under the 

Cash and Medical Assistance (CMA) 

program. The application is required by 

ORR program regulations at 45 CFR 

400.11(b). The regulation specifies that 

states must submit, as their application 

for this program, estimates of the 

projected costs they anticipate incurring 

in providing cash and medical 

assistance for eligible recipients and the 

costs of administering the program. 

Under the CMA program, states are 

reimbursed for the costs of providing 

these services and benefits for 8 months 

after an eligible recipient arrives in this 

country. The eligible recipients for these 

services and benefits are refugees, 

Amerasians, Cuban and Haitian 

Entrants, asylees, Afghans and Iraqi 

with Special Immigrant Visas, and 

victims of a severe form of trafficking. 

States that provide services for 

unaccompanied refugee minors also 

provide an estimate for the cost of these 

services for the year for which they are 

applying for grants. 

Respondents: State Agencies, the 

District of Columbia, and Replacement 

Designees under 45 CFR 400.301(c) 

administering or supervising the 

administration of programs under Title 

IV of the Act. 

ANNUAL BURDEN ESTIMATES

Instrument 

Total 

number of 

respondents 

Annual 

number of 

responses per 

respondent 

Average 

burden hours 

per response 

Annual 

burden hours 

ORR–1, Cash and Medical Assistance Program Estimates ........................... 57 1 0.6 34 

Estimated Total Annual Burden 

Hours: 34. 

Comments: The Department 

specifically requests comments on (a) 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Consideration will be given 

to comments and suggestions submitted 

within 60 days of this publication. 

(Authority: 8 U.S.C. 412(a)(4)) 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–01287 Filed 1–21–22; 8:45 am] 

BILLING CODE 4184–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Privacy Act of 1974; System of 

Records 

AGENCY: Administration for Children 

and Families, Department of Health and 

Human Services. 

ACTION: Notice of modified systems of 

records. 

SUMMARY: In accordance with the 

requirements of the Privacy Act of 1974, 


jspears on DSK121TN23PROD with NOTICES1